Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03429920 · ClinicalTrials.gov registry record · NA

Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors

A NA study of Inflammation and Heart Diseases, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT03429920 is a NA study of Inflammation and Heart Diseases that has completed, run by Loma Linda University. The registered enrollment target is 28 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03429920, a NA study of Inflammation and Heart Diseases, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This research study will test the effects of Q CAN PLUS powder on serum lipids, selected inflammatory and oxidative parameters and genome-wide methylation

Conditions Studied

Inflammation Heart Diseases Cardiovascular Risk Factor

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Q CAN PLUS

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2018-09-23
Est. Completion 2019-08-01
Phase NA

Sponsor

Loma Linda University

237 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03429920

The ClinicalTrials.gov registry entry for NCT03429920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03429920 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03429920 about?

NCT03429920 is a clinical study titled "Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors". This research study will test the effects of Q CAN PLUS powder on serum lipids, selected inflammatory and oxidative parameters and genome-wide methylation

What is the current status of trial NCT03429920?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-09-23. Estimated completion is 2019-08-01.

What conditions does trial NCT03429920 study?

This clinical trial studies the following conditions: Inflammation, Heart Diseases, Cardiovascular Risk Factor.

What interventions are being tested in trial NCT03429920?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Q CAN PLUS (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03429920?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03429920 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Inflammation

All registered trials for this condition

Heart Diseases

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.